Article citationsMore>>

Roomer, R., Hansen, B.E., Janssen, H.L. and de Knegt, R.J. (2010) Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C. Hepatology, 52, 1225-1231. doi:10.1002/hep.23842

has been cited by the following article:

• TITLE: Pulmonary aspergillosis in a patient with COPD due to PEG-interferon and ribavirin therapy for chronic hepatitis C

  AUTHORS: Ersoy Ozdal, Vardareli Eser, Getiren Seyhmus, Tozun Nurdan

  KEYWORDS: Hepatitis C; Aspergillosis; Interferon

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.2 No.1, March 25, 2013

  ABSTRACT: This is a case of 52 years old male patient with chronic obstructive pulmonary disease (COPD) who developed semi-invasive pulmonary aspergillosis while on pegylated-interferon alpha-2a and for chronic hepatitis C infection. This complication is very rarely seen during interferon therapy for other any purposes. Pulmonary aspergillosis in particular group of chronic hepatitis C patients under immunosupressive therapy should also be in mind and interdisciplinary medical cooperation might be needed during the treatment for immune-suppressed patients. Pulmonary aspergillosis is also discussed from many aspects in the light of the literature.